Moderna COVID-19 vaccine
RNA COVID-19 vaccine
Moderna COVID-19 vaccine ▸ Facts ▸ Comments ▸ News ▸ Videos
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA). Depending on the jurisdiction, it is authorized for use in people aged six months, twelve years, or eighteen years and older. It provides protection against COVID-19 which is caused by infection by the SARS-CoV-2 virus. It is designed to be administered as two or three 0.5 mL doses given by intramuscular injection at an interval of at least 28 days apart.
1 shares | ShareTweetSavePostSend |
You Might Like
Moderna sues Pfizer/BioNTech over COVID vaccineModerna is suing Pfizer and its German partner BioNTech for alleged patent infringement in the development of the first COVID-19 vaccine approved in the US.Sky News - Published | |
Indian Covid vaccines better than Pfizer, Moderna: Adar PoonawallaSerum Institute of India CEO Adar Poonawalla on Wednesday claimed that "Made in India" Covid vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and..IndiaTimes - Published | |
Pfizer and Moderna jabs give best overall boost, UK study findsThe Pfizer and Moderna vaccines being used in the UK as boosters prompt the best overall response, according to a UK trial.Sky News - Published | |
Omicron variant 'highly infectious' and COVID booster jabs may need 'double' dose, says Moderna CEOThe head of drugmaker Moderna said he believes the Omicron variant is "highly infectious" and it is "highly possible" the effectiveness of vaccines is decreasing - adding that boosters may need a..Sky News - Published | |
New variant may force drug companies to tweak Covid vaccination plansThe emergence of the Omicron strain could lead drug companies scrambling to the drawing board to tweak their Covid-19 vaccine plans. US firm Novavax and Russia’s Gamaleya Institute said on Monday..IndiaTimes - Published | |
With domestic manufacturing picking up pace, India unlikely to buy Pfizer, Moderna vaccines for now: SourcesIndiaTimes - Published | |
UK regulator approves Moderna COVID-19 vaccine for 12 to 17-year-oldsThe UK health regulator has approved the Moderna coronavirus vaccine for 12 to 17-year-olds.Sky News - Published |